Anti-SARS-CoV-2 and anticancer properties of triptolide and its derived carbonized nanomaterials
Cancer Letters · 2025
DOI: 10.1016/j.canlet.2025.217677 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2025. Verfasst von Rubina Kousar und 22 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Biomedical Sciences, China Medical University, Taichung, 406040, Taiwan; Graduate Institute of Biochemistry and Molecular Biolo…. Hauptthemen laut MEDLINE: Phenanthrenes, Diterpenes, SARS-CoV-2, Antiviral Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Medical University, National Science and Technology Council, Ministry of Education.
Abstract (Originalsprache)
The COVID-19 pandemic remains an ongoing global health threat, yet effective treatments are still lacking. This has led to a high demand for complementary/alternative medicine, such as Chinese herbal medicines for curbing the COVID-19 pandemic. Given the dual anticancer and antiviral activities of many herbal drugs, they may hold a multifaceted potential to tackle both cancer and SARS-CoV-2. Triptolide is the major bioactive compound isolated from Tripterygium wilfordii Hook F (TwHF), a traditional Chinese medicinal herb recognized for its beneficial pharmacological properties in many diseases, including cancer and viral infection. However, its application in the clinic has been greatly limited due to its toxicity and poor water solubility. Here, from a screen of a natural compound library of Chinese Pharmacopoeia, we identified triptolide as a top candidate to inhibit cell entry of SARS-CoV-2. We demonstrated that triptolide robustly blocked viral entry at nanomolar concentrations in cellular models, with broad range activity against emerging Omicron variants of SARS-CoV-2. Mechanistically, triptolide disrupted the interaction of SARS-CoV-2 spike protein with its receptor ACE2. Furthermore, we synthesized water-soluble, triptolide-derived carbon quantum dots. Compared to triptolide, these highly biocompatible nanomaterials exhibited prominent antiviral capabilities against Omicron variants of SARS-CoV-2 with less cytotoxicity. Finally, we showed that triptolide-derived carbonized materials excelled in their anticancer properties compared to triptolide and Minnelide, a water-soluble analog of triptolide. Together, our results provide a rationale for the potential development of triptolide-carbonized derivatives as a promising antiviral candidate for the current pandemic and future outbreaks, as well as anticancer agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Biomedical Sciences, China Medical University, Taichung, 406040, Taiwan; Graduate Institute of Biochemistry and Molecular Biology, China Medical University, Taichung, 406040, Taiwan; Research Cente…
- Department of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung, 20224, Taiwan.
- Department of Cancer Cell Biology, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991, Moscow, Russia.
- Research Center for Cancer Biology, China Medical University, Taichung, 406040, Taiwan; Cancer Biology and Precision Therapeutics Center, China Medical University, Taichung, 406040, Taiwan; Department of Biological Scie…
- Department of Biological Science and Technology, China Medical University, Taichung, 406040, Taiwan.
- Graduate Institute of Biomedical Sciences, China Medical University, Taichung, 406040, Taiwan; Research Center for Cancer Biology, China Medical University, Taichung, 406040, Taiwan; Cancer Biology and Precision Therape…
Förderung
- China Medical University
- National Science and Technology Council
- Ministry of Education
- Ministry of Science and Technology, Taiwan
Zitieren
APA
Kousar, R., Akhtar, T., Lin, C. J., Lebedev, T., Li, Y. C., Yang, C. C., Wang, W. J., Chen, H. F., Su, W. C., Biswas, P. K., Saqib, N. U., Belay, S. A., Chang, T. C., Guo, D. W., Li, Q., Patrick, B., Usama, M., Wu, C. S., Ma, W. L., …, & Li, X. G. (2025). Anti-SARS-CoV-2 and anticancer properties of triptolide and its derived carbonized nanomaterials. Cancer Letters. https://doi.org/10.1016/j.canlet.2025.217677
Vancouver
Kousar R, Akhtar T, Lin CJ, Lebedev T, Li YC, Yang CC, et al. Anti-SARS-CoV-2 and anticancer properties of triptolide and its derived carbonized nanomaterials. Cancer Letters. 2025. doi:10.1016/j.canlet.2025.217677
BibTeX
@article{Kousar2025,
author = {Kousar, Rubina and Akhtar, Tahira and Lin, Chin-Jung and Lebedev, Timofey and Li, Yi-Chuan and Yang, Chih-Chao and Wang, Wei-Jan and Chen, Hsiao-Fan and Su, Wen-Chi and Biswas, Pulak Kumar and Saqib, Najm Us and Belay, Sefealem Assefa and Chang, Tzu-Chi and Guo, Da-Wei and Li, Qiangdu and Patrick, Bbumba and Usama, Muhammad and Wu, Chen-Shiou and Ma, Wen-Lung and Sher, Yuh-Pyng and Huang, Chih-Ching and Hung, Mien-Chie and Li, Xing-Guo},
title = {Anti-SARS-CoV-2 and anticancer properties of triptolide and its derived carbonized nanomaterials},
journal = {Cancer Letters},
year = {2025},
doi = {10.1016/j.canlet.2025.217677}
}
EUVIMED